Medication info
Ultrapen Semi Sustained Release Tablet

Ultrapen Semi Sustained Release Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
Pale yellow, round, sustained-release film-coated tablet
Packaging
30 Tablets/ Bottle, 100 Tablets/ Bottle
Approval status
Active

MFDS item code 201604034 · Approved 2016.06.28 · Insurance code 661904710

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, the dosing interval should be at least 12 hours, and no more than 8 tablets should be taken in 1 day. Do not use this medicine for longer than necessary. If long-term administration is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should continue. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment with this medicine; monitor the patient's response closely and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

Used to relieve acute or chronic pain that ranges from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, the dosing interval should be at least 12 hours, and no more than 8 tablets should be taken in 1 day. Do not use this medicine for longer than necessary. If long-term administration is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should continue. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during treatment with this medicine; monitor the patient's response closely and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Precautions

This medication can put a strain on the liver, so those who regularly consume more than three drinks a day should consult with a doctor or pharmacist before taking this medication. This medication can rarely cause severe skin reactions, so if a skin rash or hypersensitivity reaction occurs, discontinue use immediately. The components in this medication may increase the risk of seizures, so patients with a history of seizures or those at high risk should take this medication with caution. During the use of this medication, there is a rare risk of fatal allergic reactions, so any unusual symptoms should be reported to a healthcare professional immediately. Patients with acute or severe bronchial asthma may experience severe respiratory depression while taking this medication, so it should be administered in a setting equipped with professional equipment. Taking this medication with alcohol or central nervous system depressants can lead to severe sedation or respiratory depression, so caution is advised when using them in combination. Patients with head injuries or elevated intracranial pressure should be cautious while taking this medication, as respiratory depression may worsen symptoms. This medication has the potential to cause mental and physical dependence, so careful observation for dependence is necessary during long-term use. Patients with poor liver function should consult a doctor before taking this medication, and care should be taken not to exceed a daily dosage of 4,000 milligrams. Patients with certain genotypes may have higher levels of active metabolites, increasing the risk of respiratory depression, so dosage adjustments and monitoring are required. This medication is not administered to children under 12 years of age or to certain pediatric patients post-surgery, and adolescents aged 12 to 18 years should avoid use if there are risk factors. While taking this medication, hyponatremia may occur, so it is advisable for elderly patients or those with risk factors to periodically check their sodium levels.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, rigidity, syncope, withdrawal symptoms, hypertension, worsening hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremors, ataxia, convulsions, hypertonia, migraine, worsening migraine, involuntary muscle contractions, paresthesia, confusion, vertigo, abdominal pain, constipation, diarrhea, indigestion, flatulence, dry mouth, nausea, vomiting, dysphagia, bloody stools, tongue swelling, appetite loss, anxiety, delirium, euphoria, insomnia, nervous hyperreactivity, drowsiness, forgetfulness, depersonalization, depression, drug abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thoughts, anemia, dyspnea, proteinuria, urination disorders, oliguria, urinary retention, pruritus, rash, sweating, urticaria, abnormal liver function, weight loss, tinnitus, abnormal vision, chills, vasodilation, orthostatic hypotension, bradycardia, collapse, myocardial ischemia, pulmonary edema, respiratory symptoms, bronchospasm, wheezing, angioedema, allergic reactions, anaphylaxis, Stevens-Johnson syndrome, changes in appetite, exercise weakness, respiratory depression, cognitive dysfunction, difficulty concentrating, suicidal tendencies, hepatitis, liver failure, gastrointestinal bleeding, delirium, miosis, mydriasis, speech disorders, movement disorders, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, thrombocytopenia, agranulocytosis, hypoprothrombinemia, fatigue glutamic acidosis, thrombocytopenia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, blood pressure fluctuations, pallor, cough, runny nose, elevated blood pressure, palpitations, irregular menstruation, breast cancer, injury, nausea, vomiting, urticaria, headache, constipation, indigestion, cold sweat, decreased appetite, dizziness, drowsiness, thirst, dry mouth, hyperhidrosis, rash, urination disorders, abdominal pain, insomnia, leukoplakia, rhinitis, nasopharyngitis, limb pain, joint pain, muscle cramps, muscle weakness, myalgia, blurred vision, conjunctivitis, reduced immune response, sensory disturbances, stupor, dysgeusia, involuntary muscle contractions, peripheral edema, weakness, hematuria, hematochezia, elevated cholesterol, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal vision, gallbladder cancer progression, foreign body sensation in the eye, liver cancer progression, cholecystitis, paralytic ileus, hiccups, increased salivation, colorectal cancer progression, esophageal cancer progression, gastric cancer progression, drowsiness, insomnia, anxiety, depression, nervous hyperreactivity, emotional instability, hallucinations, depersonalization, palpitations, hypertension, arrhythmia, tachycardia, worsening hypertension, aortic stenosis, congestive heart failure, confusion, worsening migraine, hypertonia, convulsions, loss of consciousness, myocardial infarction recurrence, hypotension, multiple organ failure, intentional overdose, hyperactivity, panic attacks, severe anxiety, sensory disturbances, tinnitus, abnormal central nervous system responses, withdrawal symptoms, withdrawal syndrome, opioid-induced hyperalgesia, adrenal insufficiency, paralytic ileus, cholecystitis, abnormal renal function tests, acute gastritis, generalized weakness, lethargy, heartburn, unspecified gastrointestinal disorder, acute bronchitis, exercise-related dyspnea, bronchitis, asthma, speech disorders, movement disorders, hypoglycemia, hyponatremia, thrombocytopenia, agranulocytosis, hypoprothrombinemia, fatigue glutamic acidosis, thrombocytopenia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, blood pressure fluctuations, pallor, cough, runny nose, elevated blood pressure, palpitations, irregular menstruation, breast cancer, injury, nausea, vomiting, urticaria, headache, constipation, indigestion, cold sweat, decreased appetite, dizziness, drowsiness, thirst, dry mouth, hyperhidrosis, rash, urination disorders, abdominal pain, insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is best stored at room temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow, round, sustained-release film-coated tablet

Package unit

30 Tablets/ Bottle, 100 Tablets/ Bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.